
|Slideshows|June 28, 2018
Insulin Discontinuation and Other Measures of GLP-1 RA Efficacy
Author(s)Kenneth J. Bender, PharmD, MA
What is the impact on insulin dose, A1c, body weight of adding GLP-1 RA to a MDI insulin regimen? Three studies from ADA 2018 illuminate.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
First Oral Film Treatment for Erectile Dysfunction in Men Gains FDA Approval
2
Long-Term Data Support Sustained Bimekizumab Response in Hidradenitis Suppurativa
3
Weekly Dose Podcast: New Obesity Data, Insulin Guidance, and Mental Health Screening
4
Topline Phase 2 Data Show Roflumilast Cream Improves Atopic Dermatitis in Infants as Young as 3 Months
5






























































































































